Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood Pressure Control and Mortality Among US Veterans.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Local apocynin improves acetylcholine- but not insulin-mediated vasodilation in the cutaneous microvasculature of women with a history of gestational diabetes.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Listening to the note: clinician perspectives on ambient artificial intelligence scribes in medical documentation.

Journal of the American Medical Informatics Association : JAMIA·2025
Same author

Blood Pressure and Risk of Clinical Events in Peripheral Artery Disease.

medRxiv : the preprint server for health sciences·2025
Same author

County-level vulnerability is associated with mental health and substance use treatment among rural suicide decedents: A national multi-year cross-sectional study.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2025
Same author

Suicide risk management in research: a qualitative assessment.

Journal of communication in healthcare·2025
Same journal

How I Treat a Patient with Primary Aldosteronism.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Major Adverse Kidney Events in the American Indian or Alaska Native Population with Diabetes.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

The Sexual Dimorphism in Kidney Potassium Handling: A Conceptual Review.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children.

Clinical journal of the American Society of Nephrology : CJASN·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Optimizing Hypertension Control in CKD Through Collaborative Pharmacist Interventions.

Masaaki Yamada1,2,3, Jennifer Van Tiem4, Rachel Hoskins5

  • 1Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, IA.

Clinical Journal of the American Society of Nephrology : CJASN
|June 8, 2026
PubMed
Summary
This summary is machine-generated.

Clinical pharmacists integrated into care teams significantly improve blood pressure (BP) control in chronic kidney disease (CKD) patients. Models relying on indirect recommendations are less effective, highlighting the need for better integration strategies.

Related Experiment Videos

Last Updated: Jun 10, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension is a primary driver of morbidity and mortality in chronic kidney disease (CKD).
  • Achieving optimal blood pressure (BP) control in CKD patients presents significant clinical challenges.
  • Team-based care models, especially those including clinical pharmacists, show promise for hypertension management.

Purpose of the Study:

  • To review the evidence on pharmacist-led interventions for BP management in general and specifically within CKD populations.
  • To identify the most effective models of pharmacist involvement in BP control for CKD patients.

Main Methods:

  • Systematic review of existing literature on pharmacist-led interventions for BP management.
  • Analysis of studies focusing on clinical pharmacist integration into care teams versus asynchronous recommendation models.

Main Results:

  • Pharmacist-led interventions integrated into care teams with medication management capabilities demonstrated the greatest efficacy in improving BP control.
  • Models relying on asynchronous pharmacist recommendations showed limited success in reducing BP.
  • Patients generally exhibit high acceptance of pharmacist-led interventions.

Conclusions:

  • Integrated, team-based pharmacist care is crucial for effective BP management in CKD.
  • Barriers such as workflow integration, resource limitations, and reimbursement hinder widespread implementation.
  • Further research is essential to optimize and scale pharmacist interventions for improved BP control in CKD.